Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of oral vinorelbine + cisplatin versus pemetrexed + cisplatin in first-line metastatic or locally advanced non-squamous NSCLC
2009-012001-19Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Non-small cell lung cancer (NS-NSCLC) comparing Oral vinorelbine + cisplatin with Pemetrexed + cisplatin (2 arms). Primary endpoint: Disease control rate. Started Sep 2009; status: completed.
02
Drugs
vinorelbinepemetrexedcisplatin
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on 2009-012001-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012001-19.